Parkinson's Disease
- 1 September 1984
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 41 (9) , 935-941
- https://doi.org/10.1001/archneur.1984.04050200041016
Abstract
• We examined the relationship of disease laterality to neuropsychological and neurochemical features in patients with idiopathic Parkinson's disease (PD). We tested patients with PD, patients with Alzheimer's type of senile dementia, and a control group neuropsychologically, and we determined their CSF levels of homovanillic acid, 3,4-dihydroxyphenylacetic acid, 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindolacetic acid, serotonin, and acetylcholinesterase. The patients with PD were divided into two groups depending on the side of the body with greater disease involvement. Both parkinsonian groups, those more affected on the left (group L) and those more affected on the right (group R), were otherwise similar in all other clinical and historical features. Group L patients showed greater neuropsychological impairments than group R patients. Group L also had significantly higher CSF levels of homovanillic acid and acetylcholinesterase than group R. These findings of neuropsychological and neurochemical differences between groups L and R suggest functional or anatomic asymmetries of dopaminergic systems in the CNS.This publication has 44 references indexed in Scilit:
- Subcortical DementiaPublished by Springer Nature ,2012
- Dementia in Parkinson DiseasePublished by Springer Nature ,1986
- Some psychological factors in ParkinsonismJournal of Neurology, Neurosurgery & Psychiatry, 1974
- On the origin of homovanillic acid (HVA) in the cerebrospinal fluidJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1973
- INTELLECTUAL FUNCTIONING OF PERSONS WITH IDIOPATHIC PARKINSONISMJournal of Nervous & Mental Disease, 1972
- Parkinsonism: Alterations in spatial orientation as determined by a route-walking testNeuropsychologia, 1972
- Cerebrospinal fluid levels of 3‐methoxy4hydroxyphenylethylene glycol in Parkinsonism before and after treatment with L‐DOPA1Journal of Neurochemistry, 1971
- Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonismNeurology, 1970
- COGNITIVE AND PERCEPTUAL PERFORMANCE IN PARKINSONISM AS A FUNCTION OF AGE AND NEUROLOGICAL IMPAIRMENTJournal of Nervous & Mental Disease, 1964
- A Standardized Memory Scale for Clinical UseThe Journal of Psychology, 1945